The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients
Authors
Keywords
Extranodal NK/T-cell lymphoma, Inflammation, Chemokine, CXCL13, GPS
Journal
Journal of Hematology & Oncology
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-13
DOI
10.1186/s13045-015-0142-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemokines in tumor progression and metastasis
- (2015) Purvaba J. Sarvaiya et al. Oncotarget
- Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients
- (2014) Seok Jin Kim et al. ANNALS OF HEMATOLOGY
- Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
- (2014) Seok Jin Kim et al. ANNALS OF HEMATOLOGY
- CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway
- (2014) Zhenyu Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T-cell lymphoma, nasal type
- (2013) Ya-Jun Li et al. AMERICAN JOURNAL OF HEMATOLOGY
- A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma
- (2013) M. P. Purdue et al. BLOOD
- CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis
- (2013) Subir Biswas et al. BREAST CANCER RESEARCH AND TREATMENT
- The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: A study of 826 cases from the International Peripheral T-cell Lymphoma Project
- (2012) Zdravko Mitrovic et al. AMERICAN JOURNAL OF HEMATOLOGY
- SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
- (2012) Y.-L. Kwong et al. BLOOD
- CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation
- (2011) C. P. El-Haibi et al. CELL PROLIFERATION
- Chemokines in health and disease
- (2011) Dayanidhi Raman et al. EXPERIMENTAL CELL RESEARCH
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
- (2009) Seok Jin Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
- (2009) Hyo Song Kim et al. LEUKEMIA & LYMPHOMA
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
- (2008) W.-y. Au et al. BLOOD
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started